Solventum (SOLV)Rep. James French Hill (AR02) disclosed a sale $15K–$50K
Rep. James French Hill (AR02) disclosed a sale of Solventum in the $15K–$50K range.
- $15,001–$50,000
- Reported range · official band, not an exact amount
- 23 days
- Disclosure lag
- Traded
- Dec 31, 2025
- Disclosed
- Jan 23, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 13, 20255% stakeIndependent Franchise Partners, LLP reported a passive stake (13G) of 7.4%
- Dec 31, 2025 · this disclosureCongressDisclosed sale of SOLV — reported range $15,001 - $50,000
What came next
- Jan 27, 20265% stakeIndependent Franchise Partners, LLP reported a passive stake (13G) of 8.8%
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
- Mar 10, 2026Insider · 10 days before an 8-KDirector purchased ~$100K of SOLV shares in the open market
- Mar 13, 2026FDAFDA device clearance: Promogran Prisma Collagen Matrix with ORC and Silver
- Mar 20, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 20, 2026, Mary Wilcox informed Solventum Corporation (the “Company”) of her intent to retire and resign from her position as Chief Accounting Officer of the Company following a search for and appointment of her successor.”
- Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
- Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 6.3%
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Solventum
For Solventum, OQRO holds 2 Congress trade reports and 4 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SOLV page.
Other recent filings by Rep. James French Hill (AR02)
- House Clerk periodic transaction report at Kyndryl (KD)Jan 23, 2026
- House Clerk periodic transaction report at Pfizer (PFE)Jan 23, 2026
- House Clerk periodic transaction report at Fortrea (FTRE)Jul 24, 2025
- House Clerk periodic transaction report at Vitesse Energy (VTS)Jul 24, 2025
- House Clerk periodic transaction report at AT&T (T)Jul 24, 2025
The full history of Rep. James French Hill (AR02) is on the profile page.
How this filing works
Other disclosures at Solventum
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 13, 2026
- SEC Form 13F-HRAug 7, 2026
- SEC Form 13F-HRAug 6, 2026
- Senate eFD periodic transaction reportAug 5, 2026
- Senate eFD periodic transaction reportJul 21, 2026
Everything OQRO holds on this company is on its SOLV page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data